MUC16 and cyst: Using the highly concentrated ascites and cyst fluids for initial discovery of promising biomarker combinations we subsequently proceeded to a limited scale verification of their diagnostic performance using serum samples from EOC patients and healthy and benign controls against conventional CA125 and CA19-9 references.